To further evaluate whether IFNβ conferred long-term protection against ischemic stroke with delayed tPA treatment, mice were subjected to 40min MCAO followed by vehicle, tPA, or tPA+IFNβ administration at 4.5h post-reperfusion, and the survival assay was performed. This evidence concerns the gene IFNB1 and ischemic stroke.